Skip to Content
Merck
CN
  • Correction of F8 intron 1 inversion in hemophilia A patient-specific iPSCs by CRISPR/Cas9 mediated gene editing.

Correction of F8 intron 1 inversion in hemophilia A patient-specific iPSCs by CRISPR/Cas9 mediated gene editing.

Frontiers in Genetics (2023)
Hu, et al.
MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-HNF3β/FOXA2 Antibody, Upstate®, from rabbit
Sigma-Aldrich
Monoclonal Anti-α-Fetoprotein (AFP) antibody produced in mouse, ascites fluid, clone C3